ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients

Fey, MF, Greil, R, Jost, LM Ann Oncol. 2005,16 Suppl 1:i48-9.

Long-term results of dose density therapy in patients with aggressive lymphoma.

Fridrik MA, Hausmaninger H, Linkesch W, Greil R, Krieger O, Baldinger C, Klocker J, Pont J, Oberaigner W. Ann Hematol. 2005 Apr,84(4):217-22. Epub 2004 Nov 6.

Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma.

Jöhrer K, Zelle-Rieser C, Perathoner A, Moser P, Hager M, Ramoner R, Gander H, Höltl L, Bartsch G, Greil R, Thurnher M. Clin Cancer Res. 2005 Apr 1,11(7):2459-65.

Planned first safety and efficacy analysis of oral fludarabine combined with subcutaneous alemtuzumab in 2(nd) line therapy of B-chronic lymphocytic leukaemia (B-CLL): The FLUSALEM study.

Egle, A, Tinhofer, I, Russ, G, Rass, C, Greil, R BLOOD. 2006, 108(11): 336B-336B.

IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.

Falkensammer C, Jöhrer K, Gander H, Ramoner R, Putz T, Rahm A, Greil R, Bartsch G, Thurnher M. Cancer Immunol Immunother. 2006 Oct,55(10):1228-37. Epub 2006 Jan 28.

Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.

Steurer M, Pall G, Richards S, Schwarzer G, Bohlius J, Greil R Cancer Treat Rev. 2006 Aug,32(5):377-89. Epub 2006 Jun 21. Review.

Extensive organizing pneumonia during chemo-immunotherapy containing rituximab and G-CSF in a patient with diffuse large B-cell lymphoma: case report and review of the literature.

Mian M, Rass C, Hutarew G, Kofler B, Fiegl M, Greil R. Leuk Lymphoma. 2006 Aug,47(8):1683-5.

Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemia.

Tinhofer I, Rubenzer G, Holler C, Hofstaetter E, Stoecher M, Egle A, Steurer M, Greil R. Blood. 2006 Nov 1,108(9):2950-6. Epub 2006 Jul 6.

The effect of IgVH mutational status on the induction of apoptosis by rituximab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: evidence from a clinical phase I/II trial.

Tinhofer I, Steurer M, Leitinger G, Rumpold H, Egle A, Erdel M, Greil R. Haematologica. 2006 Sep,91(9):1291-3.

Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: a nation-wide retrospective study in Austria.

Fiegl M, Falkner A, Hopfinger G, Brugger S, Zabernigg A, Bauer F, Haslbauer F, Demirtas D, Grossschmidt P, Tatzreiter G, Gastl G, Greil R Cancer. 2006 Nov 15,107(10):2408-16.